Psoriasis News and Research

Latest Psoriasis News and Research

Supplementation with omega-3 fatty acids promotes effective immune system response

Supplementation with omega-3 fatty acids promotes effective immune system response and has ameliorating effects on chronic inflammation (a condition caused by an imbalanced immune system that can lead to multiple serious illnesses over time), according to the most recent study published by the National Center for Biotechnology Information on the effects of omega-3.

31 Jan 2013

The emergency department: middle-man for pediatric referrals

Specialists are more willing to see publicly insured pediatric patients if they are referred from an emergency department rather than directly from a primary care physician, according to research findings from the USA.

29 Jan 2013

NSAIDs pose kidney risk in some children

A small but significant percentage of children develop acute kidney injury after taking nonsteroidal anti-inflammatory drugs such as ibuprofen, show study findings published in the Journal of Pediatrics.

29 Jan 2013

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 will be presented in a poster presentation at the American Association for Cancer Research Annual Meeting in Washington, DC.

23 Jan 2013

Hope for premature babies with neurologic disabilities

Damage caused by cerebral ischemia in premature babies could be reversed or prevented with early intervention, suggests research carried out in sheep and published in Science Translational Medicine.

22 Jan 2013

Hospital-based home care can work for children with cancer

Hospital-based home care is a feasible alternative for children with cancer both regarding price and efficacy, show study findings.

22 Jan 2013

Pediatric CKD rates increase substantially in south of England

Research shows that the number of children with moderate-to-severe chronic kidney disease in the south of England rose significantly between 2005 and 2009.

15 Jan 2013

Monitor white blood cell count in pertussis infants

Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.

14 Jan 2013

Glycan released by parasites might help treat metabolic disorders associated with obesity

On the list of undesirable medical conditions, a parasitic worm infection surely ranks fairly high. Although modern pharmaceuticals have made them less of a threat in some areas, these organisms are still a major cause of disease and disability throughout much of the developing world.

9 Jan 2013

Risk factors for retinopathy of prematurity identified

Birthweight and gestational age are risk factors for retinopathy of prematurity and should be considered when screening infants for the condition, a study by Turkish researchers shows.

9 Jan 2013

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional PV-10 injection of melanoma tumors.

9 Jan 2013

Trauma, infection link with stroke seen in children

Research shows that trauma and acute infection are significant risk factors for arterial ischemic stroke in children.

8 Jan 2013

Benefits of respiratory treatment for extremely premature infants persist

There are no significant differences in death or neurodevelopmental impairment between toddlers who underwent early continuous positive airway pressure or early surfactant administration as extremely premature infants, research shows.

7 Jan 2013

Researchers identify four new genetic regions associated with Behcet's disease

Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.

7 Jan 2013

Biogen Idec files rFIXFc BLA with FDA for treatment of hemophilia B

Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.

7 Jan 2013